Archive for the ‘Benzinga’ Category

A Great Day At Atlas Air HQ

Courtesy of Benzinga.

Shares of Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW) were trading up more than 30 percent on Thursday, driven by the announcement of a new deal with Amazon.com, Inc. (NASDAQ: AMZN).

The company also reported an earnings beat: Q1 Adj. EPS $0.31 vs $0.25 Est., Sales $418.615M vs $419.8M Est.

Under the terms of the agreement, Atlas Air will provide the online retailer with air cargo services to support package deliveries. The small-cap provider of outsourced aircraft and aviation services will operate 20 Boeing 767-300 converted freighters that will serve Amazon on a CMI (crew, maintenance and insurance) basis. Deliveries are projected to begin in the second half of 2016.

On top of this, the contract stipulates the retail giant receives warrants to acquire 20 percent of Atlas’s outstanding stock, at a price of $37.50 per share, at more than a 2 percent discount to the stock’s Wednesday closing price. In addition, Amazon has the option to purchase an additional 10 percent of the company over the next seven years, at the same exercise price. Shares are already trading close to $50.

Atlas Air said it expects the new deal to result in meaningful accretion to its earnings and cash flows over time, starting in 2017. “We are eager to capitalize on our ongoing initiatives and our opportunities with Amazon and Southern to drive substantial value and benefit for customers,” CEO William Flynn said in a statement.

Amazon CFO Brian Olsavsky recently explained, “The reason we add logistics capability and transportation capability is so we can serve our customers faster and faster delivery speeds and we’ve needed to add more of our own capacity to supplement our carriers and our partners.”

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Posted-In: News Movers Tech





Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Zynga Shares Rise Following Earnings Beat

Courtesy of Benzinga.

Toward the end of trading Thursday, the Dow traded down 0.10 percent to 17,634.45 while the NASDAQ declined 0.23 percent to 4,714.71. The S&P also fell, dropping 0.16 percent to 2,047.76.

Leading and Lagging Sectors

On Thursday, the energy sector proved to be a source of strength for the market. Top gainers in the sector included Legacy Reserves LP (NASDAQ: LGCY), Ameresco Inc (NYSE: AMRC), and Continental Resources, Inc. (NYSE: CLR).

In trading on Thursday, cyclical consumer goods & services shares fell by 0.53 percent. Meanwhile, top losers in the sector included Zumiez Inc. (NASDAQ: ZUMZ), down 9 percent, and Kona Grill Inc (NASDAQ: KONA), down 15 percent.

Top Headline

Merck & Co., Inc. (NYSE: MRK) reported better-than-expected earnings for its first quarter, but missed analysts’ sales estimates.

The company’s earnings advanced 21 percent to $0.40 a share from $0.33 a share in the corresponding quarter of the last year. Excluding special items, Merck’s earnings would have increased 4.7 percent to $0.89 a share from $0.85 a share in the comparable period.

The company’s revenue fell 1 percent to $9.312 billion from $9.425 billion in the previous year quarter. However, analysts were expecting earnings of $0.85 per share on revenue of $9.46 billion.

Equities Trading UP

Synacor Inc (NASDAQ: SYNC) shares shot up 123 percent to $3.15 following AT&T Inc. (NYSE: T) contract.

Shares of Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW) got a boost, shooting up 27 percent to $48.65 after the…
continue reading





Cantor Says Relypsa’s Veltassa Metrics Look Favorable

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Courtesy of Benzinga.

Positive Data Points For Veltassa Launch

Veltassa metrics look favorable so far, including a low payer rejection rate of ~20 percent, conversion from starter pack to prescriptions between 50 and 60 percent and in-line gross-to-net discount of approximately 25 percent.

Veltassa sales, albeit modest, were ahead of expectations. Veltassa sales came in at $0.6 million, compared to the 1Q16 estimate of $0.25 million. Relypsa had previously reported 1,155 outpatient prescriptions and 374 hospital/institution units sold in the quarter.

“Excluding gross-to-net discounts, sales would have been $0.8 million. Our expectation for 1H:16 has been modest, as we expect 2H:16, and in particular 4Q:16 to create visibility on Veltassa's sales potential,” analyst Mara Goldstein wrote.

Relypsa’s shares have come under pressure because investors may be viewing the debt financing as a major obstacle to a potential takeout of the company, Goldstein commented, while adding, “We continue to like the shares because of our view of the potential of Veltassa and hyperkalemia market overall.” She expects 3Q16 to be an inflection point for Veltassa, and could result in a realignment of valuation.

Latest Ratings for RLYP

Date Firm Action From To
May 2016 BTIG Research Maintains   Buy
May 2016 Cantor Fitzgerald Maintains   Buy
May 2016 Mizuho Securities Downgrades Neutral Underperform

View More Analyst Ratings for RLYP

View the Latest Analyst Ratings

Related
BTIG Cuts Veltassa Estimates, Relypsa's Price Target To $35
Mizuho Downgrades Relypsa, Says Near-Term Takeout 'Unlikely'
Relypsa's (RLYP) CEO John Orwin on Q1 2016 Results – Earnings Call Transcript (Seeking Alpha)

Posted-In: Cantor Fitzgerald Mara GoldsteinAnalyst Color Long Ideas Price Target Reiteration Analyst Ratings Trading Ideas





Goldman Raises Time Warner’s Target To $87, Lowers Warner Bros. And Turner Estimates

Courtesy of Benzinga.

Goldman Raises Time Warner's Target To $87, Lowers Warner Bros. And Turner Estimates

Time Warner Inc (NYSE: TWX) delivered a broad-based EPS beat for 1Q16. Goldman Sachs’ Drew Borst reiterated a Buy rating for the company, while raising the price target from $81 to $87. The analyst mentioned that the quarterly results reinforces Time Warner’s growth story.

Time Warner reported its 1Q16 EPS at $1.49, significantly ahead of the GS estimate of $1.30 and the consensus expectation of $1.29. The EPS beat was broad-based, with operating income ahead of expectations across all division, particularly in Warner Bros. and Turner, analyst Drew Borst said.

What The Results Mean

Despite the beat, Time Warner reiterated its 2016 guide of $5.30-$5.40, including a $0.10 forex headwind. “In our view, TWX has a history of conservatism with its guidance, particularly early in the year due to the volatility of film and foreign currency,” Borst noted. He added that a part of the 1Q beat was timing related, driven by international TV licensing deals.

Related Link: Vetr Crowd Is Very Bullish On Time Warner

Turner’s affiliate fees grew 11 percent y/y, including 15 percent growth in the US. The analyst expressed optimism regarding Time Warner’s ability to generate low-teens US fee growth in 2016-2017.

Turner ads rose 5 percent y/y, including MSD growth in the US. The company projected 2Q ad growth of MSD-HSD, which reflects “continued scatter strength and ratings tailwinds at CNN from political,” the Goldman Sachs report noted.

Estimates Reduced

The EPS estimate for 2016 remains unchanged at $5.39. The EPS estimates for 2017 and 2018 have been lowered by 2 percent on average to $6.19 and $7.13, respectively, mostly to reflect higher costs at Turner.

  • Turner: The operating profit estimate for 2016 has been reduced by 1 percent to $4.4 bn, reflecting higher programming cost and SG&A.
  • HBO: The operating profit estimate for 2016 is largely unchanged at $2.03 bn.
  • Warner Bros.:


continue reading





Regeneron Gains 4% Following Q1 Earnings Release

Courtesy of Benzinga.

Regeneron Gains 4% Following Q1 Earnings Release

Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) were trading higher by more than 4 percent early Thursday morning after the company reported its first-quarter results.

Regeneron said that it earned $2.57 per share in the first quarter on revenue of $1.2 billion. Wall Street analysts were expecting the company to earn $2.58 per share on revenue of $1.2 billion.

GAAP net income for the quarter rose to $166 million from $76 million in the same quarter a year ago, as total global sales of EYLEA rose 44 percent.

Total sales of EYLEA in the U.S. during the quarter rose to $781 million from $541 million a year ago, while net sales of EYLEA outside of the United States rose to $419 million from $292 million a year ago.

Related Link: Why Regeneron’s Praluent Is Likely To Be Removed From The U.S. Market This Year

A Phase 3 study of EYLEA for the treatment of non-proliferative diabetic retinopathy in patients without diabetic macular edema. In addition, the company held 12 other product candidates in its clinical development pipeline.

“The year is off to a very productive start at Regeneron. This quarter, we saw continued strong sales growth with EYLEA, made additional launch progress with Praluent, prepared for the potential launch of sarilumab, and reported important new data across our pipeline,” said Leonard S. Schleifer, M.D., Ph.D., president and CEO of Regeneron.

“Our innovative new therapy dupilumab showed positive results across two Phase 3 trials in moderate-to-severe atopic dermatitis, a debilitating disease with very limited treatment options, and we look forward to submitting a Biologics License Application to the U.S. FDA in the third quarter.”

Looking forward to the full fiscal year, the company expects total U.S. EYLEA net product sales to rise 20 to 25 percent growth over 2015′s level, marking an increase from the previous guidance of approximately 20 percent growth.

Posted-In: EYLEABiotech Earnings News Health Care Movers Trading Ideas General Best of Benzinga





Costco Reports Flat April Same-Store Sales, Shares Dip 1.7%

Courtesy of Benzinga.

Costco Reports Flat April Same-Store Sales, Shares Dip 1.7%

Shares of Costco Wholesale Corporation (NASDAQ: COST) were trading lower by more than 1 percent early Thursday after the company reported its April sales data.

Costco said that its total net sales for the month of April rose 3 percent year-over-year to $8.98 billion. However, comparable sales for the four-week period were flat. By region, U.S. same-store sales were flat, Canada gained 2 percent and the “Other International” segment saw a 3 percent decline.

Related Link: An Interesting Retail Pair Trade: Costco Outperform, Wal-Mart Underperform

Excluding the negative impacts from gasoline prices, deflation and foreign exchange, same-store sales would have risen 3 percent for the entire company.

At time of writing, Costco shares were down 1.66 percent in Thursday’s pre-market hours.

Posted-In: Costco Costco Monthly Sales Costco Same Store SalesNews Retail Sales Movers Trading Ideas





The Right Buyback ETF This Year

Courtesy of Benzinga.

The Right Buyback ETF This Year

The PowerShares Buyback Achievers Fund (ETF) (NYSE: PKW) will turn 10 in December, but PKW is not just one of the oldest exchange-traded funds dedicated to companies spending oodles of cash on repurchasing their own shares. PKW is also the king of the group with $1.62 billion in assets under management.

PKW’s combined heft and popularity make it easy for the ETF to overshadow its international counterpart, the PowerShares International BuyBack Achievers Portfolio (PowerShares Exchange-Traded Fund Trust II (NYSE: IPKW)). IPKW recently celebrated its second anniversary and now has $84.4 million in assets under management.

How Successful Are Buyback ETFs?

S&P 500 companies remain enthused by their own shares. In the fourth quarter, measured as November through January, share repurchases rose 5.2 percent to $136.6 billion on a year-over-year basis, according to FactSet. The research firm notes that last year, there were 70 activist-driven buyback campaigns, the highest total in a decade.

Related Link: The Benefits Of A Buyback ETF

Other developed markets are embracing the buyback game as well, highlighted by IPKW’s better than 7 percent year-to-date gain. Said another way, PKW overshadows its international cousin in size and heft, but PKW is done on the year, meaning IPKW is winning where it really matters: total returns.

What Makes IPKW Unique

“IPKW is much newer to the marketplace than its cousin PKW, having debuted in February of 2014 as compared to PKW’s launch in late 2006. Trading volume is not huge on a daily basis in this fund (approximately 33,000 shares traded daily), but this is to be expected given the “niche” nature of the fund and the fact that it is a little more than two years old at this point in time. IPKW tracks an index known as the NASDAQ International BuyBack Achievers Index and invests in ordinary shares in companies that are domiciled outside of the U.S.,” said StreetOne Financial Vice President Paul Weisbruch in a note out Wednesday.

Followers of international shareholder rewards trends will not be surprised…
continue reading





Mid-Day Market Update: Fitbit Slides On Weak Outlook; Atlas Air Worldwide Shares Shares Spike Higher

Courtesy of Benzinga.

Midway through trading Thursday, the Dow traded up 0.26 percent to 17,697.22 while the NASDAQ gained 0.10 percent to 4,730.54. The S&P also rose, gaining 0.20 percent to 2,055.23.

Leading and Lagging Sectors

On Thursday, the energy sector proved to be a source of strength for the market. Top gainers in the sector included Legacy Reserves LP (NASDAQ: LGCY), Ameresco Inc (NYSE: AMRC), and Denbury Resources Inc. (NYSE: DNR).

In trading on Thursday, cyclical consumer goods & services shares fell by 0.12 percent. Meanwhile, top losers in the sector included Zumiez Inc. (NASDAQ: ZUMZ), down 6 percent, and Kona Grill Inc (NASDAQ: KONA), down 8 percent.

Top Headline

Merck & Co., Inc. (NYSE: MRK) reported better-than-expected earnings for its first quarter, but missed analysts’ sales estimates.

The company’s earnings advanced 21 percent to $0.40 a share from $0.33 a share in the corresponding quarter of the last year. Excluding special items, Merck’s earnings would have increased 4.7 percent to $0.89 a share from $0.85 a share in the comparable period.

The company’s revenue fell 1 percent to $9.312 billion from $9.425 billion in the previous year quarter. However, analysts were expecting earnings of $0.85 per share on revenue of $9.46 billion.

Equities Trading UP

Synacor Inc (NASDAQ: SYNC) shares shot up 126 percent to $3.19 following AT&T Inc. (NYSE: T) contract.

Shares of Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW) got a boost, shooting up 22 percent to $46.83 after the company disclosed that it would provide air cargo services to Amazon.com, Inc. (NASDAQ: AMZN) to support…
continue reading





JPMorgan Expects Priceline To Trade Down Amid Q2 Outlook

Courtesy of Benzinga.

Priceline Group Inc (NASDAQ: PCLN) reported strong 1Q earnings, with FXN total gross bookings growth of 26 percent y/y, gross profit growth of 21 percent y/y growth and non-GAAP EPS of $10.54. JPMorgan’s Doug Anmuth maintained an Overweight rating for the company, with a price target of $1,510.

Subdued 2Q Guidance

Although Priceline reported better-than-expected 1Q results, the guidance for 2Q16 was disappointing. The company guided to 2Q total gross bookings growth of 11-18 percent and EBITDA of $740-$795 million, lower than consensus expectations of 21 percent growth and $950 million, respectively.

“While 1Q results were solid, soft 2Q guide came as a surprise, and we look for more clarity on the drivers behind the steep deceleration in both bookings growth and EBITDA guide for 2Q. We expect PCLN shares to trade down on the 2Q outlook,” analyst Doug Anmuth wrote.

Anmuth believes that Priceline is the best positioned company in the online travel space and is poised to continue gaining share in international markets. He added, “We look for strong International bookings growth in 2016, driven by Booking.com, Agoda, KAYAK, and Rentalcars.com, along with a more stable European macro environment.”

Latest Ratings for PCLN

Date Firm Action From To
May 2016 Credit Suisse Maintains Outperform
May 2016 JMP Securities Maintains Market Outperform
May 2016 Cantor Fitzgerald Maintains Buy

View More Analyst Ratings for PCLN


View the Latest Analyst Ratings

Posted-In: Doug Anmuth JPMorganAnalyst Color Long Ideas Reiteration Analyst Ratings Trading Ideas





Fast Casual Bulls: Bojangles, Wingstop Beat Estimates And Guide Strong

Courtesy of Benzinga.

Bojangles Inc (NASDAQ: BOJA) and Wingstop Inc (NASDAQ: WING) both reported their first quarter financial results after the market closed on Thursday.

Bojangles posted EPS of $0.21 on revenue of $127.66 million (up 11.3 percent year-over-year), beating the Street’s consensus by $0.03 and $1.52 million, respectively.

In addition, management guided for full year EPS of $0.89 to $0.93, above consensus of $0.88, on revenue of $535 million to $543 million, mostly under the $542.44 million estimate.

For its part, Wingstop issued EPS of $0.15, $0.01 above the Street’s consensus, on revenue of $22.1 million, which were up 16.3 percent year-over-year, and beat estimates of $21.46 million.

For the full year, the company said it expects EPS of $0.57, $0.01 above the Street’s consensus, on revenue of $89 million to $90 million, versus estimates of $89.58 million.

Posted-In: Earnings News Guidance After-Hours Center Movers





 
 
 

ValueWalk

Donald Trump - How the Ghost of Watergate Haunts This Election

By Jacob Wolinsky. Originally published at ValueWalk.

Donald Trump – How the Ghost of Watergate Haunts This Election

There is a line of reasoning in political circles that says Barack Obama created the phenomenon of Donald Trump.

I aver that Donald Trump is a creation of the post-Watergate media. Collectively we have made running for office so abso...



more from ValueWalk

Zero Hedge

Will Turkey Become An "Islamic State"?

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Submitted by Emad Mostaque via GovernmentsAndMarkets.com,

“Erdogan once said that democracy, for him, is a bus ride … ‘once I get to my stop, I’m getting off’ ”

Jordan’s King Abdullah recalling a conversation with the Turkish President

Tonight is H?drellez in Turkey, celebrating spring and the day on which the Prophets al-Khidr and Elijah.

Traditionally wishes come true today and it would seem th...



more from Tyler

Phil's Favorites

PhilStockWorld.com Weekly Trading Webinar - 05-04-16

Watch yesterday's stock and option trading webinar below. (Subscribe to PSW's YouTube channel here.)

PhilStockWorld.com Weekly Trading Webinar - 05-04-16

Don't miss next week's webinar in real-time. Get LIVE access to Phil's Weekly Webinars by joining us at Phil's Stock World — click here!)

Major Topics

00:01:51 Checking on the Markets: CL, RUSSEL, INDEX, DX, SI, YG, AAPL, BA, WYNN, AMZN, TSLA, NG, TLT, NASDAQ, NKD
00:06:52 Trade Ideas: RUSSEL, AAPL, NASDAQ
00:18:50 AAPL: Bull calls spread, Long Term Portfolio, Trade Ideas
00:23:50 BHI: Puts and Calls, Trade Ideas
00:26:20 Theory on TWTR and F...



more from Ilene

Chart School

S&P 500 Snapshot: Market Stalls in Advance of Tomorrow's Jobs Report

Courtesy of Doug Short's Advisor Perspectives.

Major markets around the globe saw little price movement today. Our benchmark S&P 500 rallied at the open, despite the biggest jump in new unemployment claims since January of 2015. The index hit its modest 0.44% intraday high about 45 minutes into the session. It then sold off to its -0.26% early afternoon low. The index then struggled to its -0.02% close. The 500 essentially went nowhere in advance of tomorrow employment report for April.

The yield on the 10-year note closed at 1.76%, down three basis points from the previous.

Here is a snapshot of past five sessions in the S&P 500.

Here is a daily chart of the index. Volume in today's decline was unremarkable.

A Perspective on Drawdowns...



more from Chart School

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Market News

News You Can Use From Phil's Stock World

 

Financial Markets and Economy

The Unloved Business That's Saved Big Oil From Low Energy Prices (Bloomberg)

Big Oil is suddenly Big Chemical.

Oil rallies as Canada fire and Libya violence threaten supply (Reuters)

A huge wildfire near Canada's oil sands region and escalating tensions in Libya stoked concern among investors over a near-term supply shortage, driving crude prices up for the first time in a week on Thursday.

The 9 bes...



more from Paul

Digital Currencies

"I Can Only Say I'm Sorry" - Self-Professed Bitcoin "Creator" Can't Provide Proof, Backs Out

Courtesy of ZeroHedge. View original post here.

Two years after Newsweek wrote an inaugural article upon returning to print in which it "unmasked" bitcoin creator Satoshi Nakamoto and which turned out be a hoax (the author "found" Nakamoto using a white pages search), earlier this week the world was fixated on the story of another self-professed bitcoin "creator", this time Australian entrepreneuer Craig Wright, who &quo...



more from Bitcoin

Kimble Charting Solutions

S&P 500- Reversal patterns taking place of late at resistance

Courtesy of Chris Kimble.

How many of you like “Choppy/Sideways” markets? I humbly suspect that most don’t. They do present some short-term trading opportunities for sure, nothing wrong with that. From a trend perspective, I would understand if some think a sideways pattern is boring.

Below takes a close look at the S&P 500 over the past couple of years.

CLICK ON CHART TO ENLARGE

The S&P 500 has spent the last couple of years, forming...



more from Kimble C.S.

Biotech

Cantor Says Relypsa's Veltassa Metrics Look Favorable

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Courtesy of Benzinga.

Relypsa Inc (NASDAQ: RLYP) shares have plummeted 51 percent year-to-date, under pressure from debt-financing related concerns. Cantor Fitzgerald’s Mara Goldstein reiterated a Buy rating for the company, while reducing the price target from $42 to $41. The analyst believes the 1Q16 results would be “a stabilizing force for the shares.”

Positive Data Points For Veltassa Launch

Veltassa metrics look favorable so far, including a low payer rejecti...



more from Biotech

OpTrader

Swing trading portfolio - week of May 2nd, 2016

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Mapping The Market

About that debate last night

Although we try to stay focused on finding and managing promising trade ideas, the comments in the comment section sometimes take a political turn (for access, try PSW — click here!). So today, Jean Luc writes,

The GOP debate last night was just unreal – are these people running to be president of the US or to lead a college fraternity! Comparing tool size? The only guy that looks semi-sane is Kasich. The other guys are just like 3 jackals right now. 

And something else – if Trump is the candidate, that little Romney speech yesterday is probably already being made into a commercial. And all these little snippets from the debate will also make some nice ads! If you are a conservative, you have to be scared now. 

Phil writes back,

I was expecting them to start throwing poop at each other &n...



more from M.T.M.

Promotions

PSW is more than just stock talk!

 

We know you love coming here for our Stocks & Options education, strategy and trade ideas, and for Phil's daily commentary which you can't live without, but there's more!

PhilStockWorld.com features the most important and most interesting news items from around the web, all day, every day!

News: If you missed it, you can probably find it in our Market News section. We sift through piles of news so you don't have to.   

If you are looking for non-mainstream, provocatively-narrated news and opinion pieces which promise to make you think -- we feature Zero Hedge, ...



more from Promotions

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!




FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>